Breast implants may be linked to rare cancer: FDA | Reuters
Women with breast implants may face an increased risk of a rare immune-system cancer near their implants, U.S. regulators said on Wednesday.
Health officials need more data to tell if the implants are related to the cancer and are asking doctors to report any confirmed cases, the Food and Drug Administration said in a statement. Overall the agency still considers implants safe.
The cancer warning could hit sales of silicone-gel and saline implants sold by Allergan Inc and Johnson & Johnson's Mentor unit. Allergan shares fell more than 2 percent.
No comments:
Post a Comment